Glaucoma is a chronic, progressive and irreversible neuropathy of the optic nerve, characterized by morphological changes in the optic nerve papilla and defects in the visual field. Although the precise pathogenesis is not fully understood, the current concept of glaucoma development incorporates the deformation of the lamina cribrosa caused by elevated intraocular pressure, leading to axonal damage, subsequent apoptosis of retinal ganglion cells and loss of the nerve fiber layer. This review article discusses the current possibilities of using minimally invasive glaucoma surgery, specifically focusing on the micro-invasive implants iStent and Preserflo, their efficacy and safety in the surgical treatment of primary open-angle glaucoma.
- Minimally Invasive Glaucoma Surgery: iStent and Preserflo in the Treatment of Primary Open-Angle Glaucoma. A Review
- Choroidal Neovascular Membrane in Pediatric Patients: Long-Term Outcomes of Anti-VEGF Therapy
- Clinical Outcomes of Preserflo MicroShunt versus Trabeculectomy: A Retrospective 6-Month Study
- Metric Causes of Refractive Errors of the Eye
- Outcomes of Chandelier-Assisted Segmental Scleral Buckling Compared to Conventional Scleral Buckling for Primary Rhegmatogenous Retinal Detachment: A comparative retrospective study
- Subretinal Triamcinolone Acetonide and Transpupillary Thermotherapy in Circumscribed Choroidal Hemangioma. A Case Report